Wells Fargo lowered the firm’s price target on Bath & Body Works to $33 from $44 and keeps an Overweight rating on the shares. The firm is also cutting Q3 estimates, and more notably pruning 2026 EPS well below Street. Wells believes turnaround efforts are likely to be pushed out to 2026 as new CEO Heaf takes more time to reinvest in the current model.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works put volume heavy and directionally bearish
- Bath & Body Works price target lowered to $28 from $32 at Barclays
- Bath & Body Works price target lowered to $28.50 from $32 at Jefferies
- Bath & Body Works downgraded to Neutral from Overweight at JPMorgan
- Trump Weekly: President threatens new tariffs, announces TikTok deal